Quantcast

Latest Emergent BioSolutions Stories

2014-05-21 08:28:31

DALLAS, May 21, 2014 /PRNewswire/ -- ReportsnReports.com offers "Vaccines: The End of Illness" and other vaccine market research reports focusing on vaccine technology, HIV, China's animal vaccine industry and cancer vaccine partnering terms and agreements. Vaccines: The End of Illness 2014 market research report focuses on the most recent vaccine research [http://www.reportsnreports.com/reports/286914-vaccines-the-end-of-illness.html ], emphasizing their reputation as...

2014-04-08 12:31:33

ROCKVILLE, Md., April 8, 2014 /PRNewswire/ -- Biologics development and manufacturing services provider Omnia Biologics, Inc. (Omnia) (Rockville, MD) today announced that Karen Hughes has joined the Omnia team as Senior Director of Quality Assurance and Quality Control. Over the course of her nearly 23 year career in quality assurance, she has held quality positions of increasing responsibility in the manufacturing of pioneering pharmaceutical and biologic products. Karen worked for...

2013-10-02 23:19:21

Reportbuyer.com just published a new market research report: Global Vaccine Market Forecast to 2017. London (PRWEB) October 02, 2013 Of late, the vaccines market is burgeoning with immense activities. Big pharmaceutical companies like GSK, Pfizer, Merck etc. are struggling to maintain their revenue and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and the potential to generate blockbuster...

2011-01-10 15:30:00

ANNAPOLIS, Md., Jan. 10, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has strengthened its research and development and program management functions with the addition of several new leadership appointments. Namely, Ms. Susan Linna has been appointed Vice President of Program Management; Dr. Kevin Connolly has joined the organization as Senior Program Director for rPA-based anthrax vaccines; and Dr. Kimberly Taylor has joined the organization as Senior...

2010-11-03 08:00:00

MERIDEN, Conn., Nov. 3, 2010./PRNewswire/ -- Protein Sciences Corporation (PSC) announced today that the Company and its management have reached an agreement with Emergent BioSolutions, Inc (Emergent) resolving all remaining issues from the failed attempt by Emergent to purchase PSC's assets in June 2008. As a result, all litigation will be dismissed with prejudice and all other entanglements between the two companies will be ended. Daniel Adams, Executive Chairman, said, "With this deal...

2010-10-08 02:00:45

Research to focus on improving delivery of dengue and anthrax vaccines The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack. Each project focuses on simple and efficient vaccine delivery approaches that could be deployed quickly. The total funding for the three...

2010-09-08 15:00:00

SEATTLE, Sept. 8 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion by Emergent BioSolutions Inc. (NYSE: EBS) announced on Aug. 12, 2010. Accordingly, the requirement under the merger agreement for the...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related